Evaluating the Diversity and Target Addressability of DELs using Scaffold Analysis and Machine Learning
News
The Discovery and Preclinical Profile of ALG-000184, a Prodrug of the Potent Hepatitis B Virus Capsid Assembly Modulator ALG-001075
Discovery of UCB9386: A Potent, Selective, and Brain-Penetrant Nuak1 Inhibitor Suitable for In Vivo Pharmacological Studies
October 2024: Breast Cancer Awareness Month
Novalix’s commitment to disability awareness
Nanoclick as potential tool to assess receptor mediated internalization
NovAliX and Bruker forge global alliance to transform drug discovery capabilities and elevate CRO service excellence
Determining the Affinity and Kinetics of Small Molecule Inhibitors of Galectin-1 Using Surface Plasmon Resonance
Minister Franck Riester visits NovAliX site in Val-de-Reuil
On a seamlessly replicable circular photoreactor for lab-scale continuous flow applications